Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot ...

Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released. Semaglutide is a glucagon-like ...

The RetinalGeniX™ imaging system is designed to allow routine screenings to be conducted by general practitioners, optometric ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Diabetic retinopathy is the number one preventable cause of blindness. To avoid it, simply take care of your diabetes. Two ...

Joslin Diabetes Center investigators led a study which looked at cognitive function and brain pathology in aging people with ...

As the world prepares for a “diabetes tsunami,” eye care experts believe AI could be key to saving health systems money.

The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

“One of the concerns is that diabetes in the western region is actually higher than the average in Jamaica. Whereas I ...

Researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based diagnostics for neurodegenerative diseases.

Aharon, Ph.D., Co-Founder & CEO of AEYE Health, in conversation with Jake Laznik, Senior Breaking News Desk Manager, The ...

Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular degeneration (AMD).